Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Medical Device
China’s Jiangsu Bioda Gains NMPA Approval for Innovative Artificial Blood Vessel
January 30, 2025
Company
Drug
Visen Pharmaceuticals Publishes Phase III Data for Lonapegsomatropin in Growth Hormone Deficiency
January 30, 2025
Company
Deals
RongCan Biotech Raises Pre-Series A Funding for mRNA Therapeutics Development
January 30, 2025
Company
Lee’s Pharmaceutical Reports Q3 2022 Financials with 8.8% Revenue Growth
January 30, 2025
Company
Deals
Marinus Pharmaceuticals Collaborates with Tenacia Biotechnology for Ganaxolone
January 30, 2025
Company
Legal / IP
Mirati Therapeutics Sues InventisBio Over Trade Secret Misappropriation
January 30, 2025
Legal / IP
Policy / Regulatory
CDE Issues Trial Rules for NMPA Drug Review Timekeeping Suspension
January 31, 2025
Company
Medical Device
Bio-Heart Bio to Launch Clinical Study for Rapamycin Drug-Eluting Balloon in Japan
January 31, 2025
Company
Medical Device
Bio-Heart Bio Receives Ethical Approval for Iberis RDN System in Hainan
January 31, 2025
Company
Drug
BeiGene’s Brukinsa Receives EC Approval for CLL Treatment
January 31, 2025
Company
Zhangjiang AI New Drug R&D Alliance Expands with New Members
January 31, 2025
Company
Deals
Subtle Medical Secures Series B Funding for AI-Powered Medical Imaging
January 31, 2025
1
2
…
7
8
9
10
11
…
24
25
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
